Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Groupon Q4 Loss Widens, Shares Plunge

RELATED NEWS
Trade GRPN now with 

Groupon Inc. (GRPN: Quote) Thursday reported fourth-quarter net loss of $81.1 million or $0.12 per share, wider than loss of $65.4 million or $0.12 per share last year. Following the news, shares plunged 24 percent in after hours trade.

Revenues for the quarter grew 30 percent to $638.3 million from $492.2 million last year.

Analysts polled by Thomson Reuters expected the company to earn $0.03 per share on revenues of $638.4 million for the quarter. Analysts' estimates typically exclude special items.

Looking forward to the first quarter of 2013, the company expects revenues of $560 million to $610 million. Analysts currently estimate revenues of $650.29 million.

Click here to receive FREE breaking news email alerts for Groupon, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.